Piotr Krzeski

1.8k total citations · 1 hit paper
14 papers, 1.3k citations indexed

About

Piotr Krzeski is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Piotr Krzeski has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Genetics and 5 papers in Surgery. Recurrent topics in Piotr Krzeski's work include Inflammatory Bowel Disease (8 papers), Microscopic Colitis (6 papers) and Colorectal Cancer Screening and Detection (3 papers). Piotr Krzeski is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Microscopic Colitis (6 papers) and Colorectal Cancer Screening and Detection (3 papers). Piotr Krzeski collaborates with scholars based in United States, United Kingdom and Canada. Piotr Krzeski's co-authors include Bruce Yacyshyn, William J. Sandborn, Brian G. Feagan, Simon Travis, Dan Schnell, Stephen B. Hanauer, Gary R. Lichtenstein, Bruce E. Sands, Christian A. Bernhardt and Douglas G. Altman and has published in prestigious journals such as Gastroenterology, Journal of the American College of Cardiology and Hepatology.

In The Last Decade

Piotr Krzeski

13 papers receiving 1.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

2011 441 citations Simon Travis, Dan Schnell et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Piotr Krzeski United States	8	854	704	472	273	137	14	1.3k
Conor P. Delaney United States	16	509 0.6×	385 0.5×	649 1.4×	134 0.5×	41 0.3×	27	1.0k
Spyros I. Siakavellas Greece	21	336 0.4×	435 0.6×	226 0.5×	124 0.5×	72 0.5×	48	993
Satoru Umegae Japan	23	1.2k 1.5×	930 1.3×	658 1.4×	128 0.5×	39 0.3×	53	1.5k
C. Penna France	19	408 0.5×	342 0.5×	727 1.5×	776 2.8×	135 1.0×	52	1.6k
U. Heuschen Germany	15	607 0.7×	528 0.8×	644 1.4×	363 1.3×	54 0.4×	32	1.2k
David G. Forcione United States	26	175 0.2×	344 0.5×	1.3k 2.8×	870 3.2×	51 0.4×	71	1.9k
Alex Kartheuser Belgium	25	200 0.2×	173 0.2×	948 2.0×	1.0k 3.8×	198 1.4×	86	2.0k
Kevin Turner United States	21	159 0.2×	243 0.3×	729 1.5×	211 0.8×	153 1.1×	75	1.2k
Hülya Çetınkaya Türkiye	17	209 0.2×	472 0.7×	162 0.3×	139 0.5×	112 0.8×	48	989
Yuga Komaki Japan	16	359 0.4×	342 0.5×	264 0.6×	139 0.5×	77 0.6×	47	882

Countries citing papers authored by Piotr Krzeski

Since Specialization

Citations

This map shows the geographic impact of Piotr Krzeski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Krzeski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Krzeski more than expected).

Fields of papers citing papers by Piotr Krzeski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piotr Krzeski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Krzeski. The network helps show where Piotr Krzeski may publish in the future.

Co-authorship network of co-authors of Piotr Krzeski

This figure shows the co-authorship network connecting the top 25 collaborators of Piotr Krzeski. A scholar is included among the top collaborators of Piotr Krzeski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piotr Krzeski. Piotr Krzeski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Ray, Adrian S., Dan Cui, Gillian Bain, et al.. (2021). P306 MORF-057, an oral selective α4β7 integrin inhibitor for Inflammatory Bowel Disease, leads to specific target engagement in a single and multiple ascending dose study in healthy subjects. Journal of Crohn s and Colitis. 15(Supplement_1). S333–S335. 4 indexed citations

Travis, Simon, Dan Schnell, Brian G. Feagan, et al.. (2015). The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS]. Journal of Crohn s and Colitis. 9(8). 607–616. 45 indexed citations

Winter, Harland S., Piotr Krzeski, Melvin B. Heyman, et al.. (2014). High‐ and Low‐Dose Oral Delayed‐Release Mesalamine in Children With Mild‐to‐Moderately Active Ulcerative Colitis. Journal of Pediatric Gastroenterology and Nutrition. 59(6). 767–772. 10 indexed citations

Sandborn, William J., Dan Schnell, Piotr Krzeski, et al.. (2013). 558 Influence of Symptom Knowledge and History on Disease Scoring With the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gastroenterology. 144(5). S–103.

Travis, Simon, Dan Schnell, Piotr Krzeski, et al.. (2013). Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity. Gastroenterology. 145(5). 987–995. 328 indexed citations

Travis, Simon, Dan Schnell, Piotr Krzeski, et al.. (2011). Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut. 61(4). 535–542. 441 indexed citations breakdown →

Sandborn, William J., Jarosław Reguła, Brian G. Feagan, et al.. (2009). Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis. Gastroenterology. 137(6). 1934–1943.e3. 119 indexed citations

Travis, Simon, William J. Sandborn, Stephen B. Hanauer, et al.. (2009). 1049 Identification of Items to Be Included in An Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gastroenterology. 136(5). A–160. 3 indexed citations

Sandborn, William J., Jarosław Reguła, Brian G. Feagan, et al.. (2008). 702 Efficacy and Safety of Delayed-Release Oral mesalamine At 4.8g/D (800mg Tablet) in the Treatment of Moderately Active Ulcerative Colitis: Results of the Ascend III Study. Gastroenterology. 134(4). A–99. 7 indexed citations

10.

Sandborn, William J., et al.. (2008). Developing an Ulcerative Colitis Endoscopic Index of Severity (Uceis). The American Journal of Gastroenterology. 103. S494–S495. 2 indexed citations

11.

Krzeski, Piotr, Chris Buckland‐Wright, Géza Bálint, et al.. (2007). Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study. Arthritis Research & Therapy. 9(5). R109–R109. 167 indexed citations

12.

Hudson, Michael, Paul W. Armstrong, Witold Rużyłło, et al.. (2006). Effects of Selective Matrix Metalloproteinase Inhibitor (PG-116800) to Prevent Ventricular Remodeling After Myocardial Infarction. Journal of the American College of Cardiology. 48(1). 15–20. 160 indexed citations

13.

Abreu, María T., Simon Travis, Rachel Cooney, et al.. (2006). Conduct of Clinical Trials in UC. The American Journal of Gastroenterology. 101. S429–S430. 4 indexed citations

14.

Krzeski, Piotr, et al.. (1999). Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis?. Hepatology. 30(4). 865–869. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact